| 12:30-13:00 |
등록 |
|
| 13:00-13:10 |
개회사 |
강석구(대한뇌종양학회 회장) |
| 13:10-13:20 |
뇌종양 치료 인증기관 사업 소개 |
김용휘(뇌종양 치료 인증기관 위원장) |
|
Glioma Session |
좌장: 문경섭(전남대) |
| 13:30-13:50 |
Molecular imaging in glioma |
신일아(가톨릭대 영상의학과) |
| 13:50-14:10 |
Natural history and the previous treatment paradigms of Grade 2 and 3 IDH-mutant glioma |
김경민(인하대) |
| 14:10-14:30 |
Updated management and emerging therapies of Grade 2 and 3 IDH-mutant glioma |
강호(서울대) |
| 14:30-14:45 |
coffee break |
|
| 14:45-15:05 |
Functional preservation surgery of Grade 4 IDH-wildtype glioma |
최선아(연세대) |
| 15:05-15:25 |
Precision neuro-oncology and future directions of Grade 4 IDH-wildtype glioma |
이채진(경북대) |
| 15:25-15:40 |
coffee break |
|
|
Meningioma Session |
좌장: 박경재(고려대) |
| 15:40-16:00 |
Updated molecular pathology of meningioma |
이 현(가톨릭대 병리과) |
| 16:00-16:20 |
Natural history and growth prediction of Grade 1 meningioma |
김영진(전남대) |
| 16:20-16:40 |
Strategies to minimized resection-related morbidity of Grade 1 meningioma |
신동원(가천대) |
| 16:40-16:55 |
coffee break |
|
| 16:55-17:15 |
Current evidence and ongoing clinical trials of Grade 2/3 meningioma |
변유경(울산대) |
| 17:15-17:35 |
Modern radiotherapy and radiosurgery of Grade 2/3 meningioma |
이치형(부산대) |
